European Union member state
Medical literature search aligned with Bulgaria’s national guidelines
As a European Union member state, Bulgaria aligns medicines regulation with the European Medicines Agency (EMA), while NCPRMP — National Council on Prices and Reimbursement of Medicinal Products — anchors national clinical guidance.
Reference bodies for Bulgaria
- NCPRMP— National Council on Prices and Reimbursement of Medicinal Products
- EMA— European Medicines Agency
Evidence a clinician in Bulgaria can audit
Ask a clinical question in natural language. eUvidence retrieves the relevant peer-reviewed papers, extracts the passages that bear on the question, and returns a cited summary. The reference list stays visible alongside the answer, so every sentence can be traced to a specific paper — title, journal, year, and DOI — and opened in one click.
The corpus is restricted to peer-reviewed journals and European regulatory and HTA references. That keeps answers anchored to the same evidence base that national bodies such as NCPRMP and the EMA draw on, rather than the open web.
Frequently asked questions
- Does eUvidence cover Bulgaria's national guidelines?
- eUvidence searches peer-reviewed medical literature and weights the answer toward the references a clinician in Bulgaria works from — the national guidance associated with NCPRMP (National Council on Prices and Reimbursement of Medicinal Products) and EU-level sources such as the EMA. Every claim in a summary cites the underlying paper so you can verify it.
- Is eUvidence a medical device in Bulgaria?
- No. eUvidence is a literature search and synthesis tool. It is not a medical device under EU MDR, has not been certified in Bulgaria or elsewhere, and does not provide diagnosis or treatment recommendations. Results are summaries of published research; clinical decisions remain the responsibility of the treating clinician.
- What is NCPRMP?
- NCPRMP is National Council on Prices and Reimbursement of Medicinal Products — the body in Bulgaria associated with national clinical guidance or health-technology assessment. eUvidence does not republish its documents; it surfaces the peer-reviewed evidence that underpins clinical questions and lets you audit each source.
- Which sources does eUvidence search?
- Peer-reviewed medical journals indexed via standard databases, plus European regulatory and HTA references (EMA, NICE, HAS, KCE and equivalents). No preprints, no conference abstracts surfaced as primary evidence, no pharmaceutical marketing content.
Coverage across Europe
eUvidence aligns with national guidance across the EU, the UK, Ukraine, and the EEA. Explore another country: